###begin article-title 0
An MHC class Ib-restricted CD8 T cell response confers antiviral immunity
###end article-title 0
###begin p 1
###xml 33 50 33 50 <email xmlns:xlink="http://www.w3.org/1999/xlink">alukach@emory.edu</email>
CORRESPONDENCE Aron E. Lukacher: alukach@emory.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 358 362 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 363 367 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 490 494 490 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 495 499 495 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 569 573 569 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 665 666 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 827 831 817 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 832 836 822 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 959 963 949 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
Although immunity against intracellular pathogens is primarily provided by CD8 T lymphocytes that recognize pathogen-derived peptides presented by major histocompatibility complex (MHC) class Ia molecules, MHC class Ib-restricted CD8 T cells have been implicated in antiviral immunity. Using mouse polyoma virus (PyV), we found that MHC class Ia-deficient (Kb-/-Db-/-) mice efficiently control this persistently infecting mouse pathogen. CD8 T cell depletion mitigates clearance of PyV in Kb-/-Db-/- mice. We identified the ligand for PyV-specific CD8 T cells in Kb-/-Db-/- mice as a nonamer peptide from the VP2 capsid protein presented by Q9, a member of the beta2 microglobulin-associated Qa-2 family. Using Q9-VP2 tetramers, we monitored delayed but progressive expansion of these antigen-specific CD8alphabeta T cells in Kb-/-Db-/- mice. Importantly, we demonstrate that Q9-VP2-specific CD8 T cells more effectively clear wild-type PyV than a VP2 epitopenull mutant PyV. Finally, we show that wild-type mice also generate Q9-restricted VP2 epitope-specific CD8 T cells to PyV infection. To our knowledge, this is the first evidence for a defined MHC class Ib-restricted antiviral CD8 T cell response that contributes to host defense. This study motivates efforts to uncover MHC class Ib-restricted CD8 T cell responses in other viral infections, and given the limited polymorphism of MHC class Ib molecules, it raises the possibility of developing peptide-based viral vaccines having broad coverage across MHC haplotypes.
###end p 3
###begin p 4
###xml 24 25 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 32 33 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 206 211 <span type="species:ncbi:10090">mouse</span>
Abbreviations used: beta2m, beta2 microglobulin; KLRG1, killer cell lectin-like receptor subfamily G, member 1; LT, large T antigen; LT359, aa 359-368 of LT; MT, middle T antigen; p.i., postinfection; PyV, mouse polyoma virus; VP2.139, aa 139-147 of the VP2 PyV capsid protein.
###end p 4
###begin p 5
C.-R. Wang's present address is Dept. of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
###end p 5
###begin p 6
###xml 366 369 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD1</italic>
###xml 374 377 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MR1</italic>
###xml 395 396 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 416 417 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 694 695 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 808 809 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 810 811 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
Immunosurveillance for intracellular pathogens is primarily mediated by conventional TCRalphabeta CD8 T lymphocytes that recognize pathogen-derived oligopeptides presented by "classical" MHC class Ia molecules (the H-2K, D, and L molecules in the mouse). Yet, a sizeable number of H-2D distal genes in the Q, T, and M regions of the mouse MHC and the non-MHC-linked CD1 and MR1 genes encode beta2 microglobulin (beta2m)-associated class I glycoproteins. Compared with MHC class Ia molecules, these "nonclassical" class Ib molecules have limited polymorphism, low-level ubiquitous or tissue-specific expression, truncated cytoplasmic/transmembrane domains, and/or alternative splicing patterns (1). Several class Ib molecules have been shown to mediate immunoregulatory as well as nonimmunological functions (2-6).
###end p 6
###begin p 7
###xml 326 348 326 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria monocytogenes</italic>
###xml 350 376 350 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 382 404 382 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella typhimurium</italic>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 574 589 574 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. typhi</italic>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 326 348 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 350 376 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 382 404 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 574 589 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 673 681 <span type="species:ncbi:90370">S. typhi</span>
CD8 T cells restricted by MHC class Ib molecules have also been implicated in microbial defense. In particular, the mouse class Ib molecules H2-M3, CD1d (and human CD1), and Qa-1 (and its human orthologue HLA-E) serve as TCR restriction elements for CD8 T cells that provide immunity against intracellular bacteria, including Listeria monocytogenes, Mycobacterium tuberculosis, and Salmonella typhimurium, respectively (7-9). H2-M3 preferentially presents N-formyl peptides, and CD1 presents mycobacterial lipid antigens to nonconventional T cells implicated in immunity to M. tuberculosis infection. Other than Qa-1 and HLA-E, which present the GroEL nonamer peptide from S. typhi, there are few examples of class Ib molecules that present "class Ia-like" peptides and none that serve as ligands for CD8 T cells that fight nonbacterial pathogens (1).
###end p 7
###begin p 8
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 516 518 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 568 569 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 659 663 642 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 664 668 647 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 822 824 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 480 483 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
Limited evidence suggests that class Ib-restricted CD8 T cells may also contribute to viral immunity. Early studies identified a nonformylated peptide derived from the influenza virus hemagglutinin that induced an in vitro primary expansion of H2-M3-restricted CD8 CTLs, but these CTLs were unable to kill influenza virus-infected cells (10, 11). In addition, HLA-E-restricted TCRalphabeta CD8 CTL cloned lines recognizing a nonamer peptide derived from the UL40 protein of human CMV have been previously described (12). Recently, Braaten et al. demonstrated that beta2m-dependent TCRalphabeta CD8 T cells in mice selectively lacking MHC class Ia molecules (Kb-/-Db-/- mice) controlled chronic infection by rodent gamma-herpesvirus 68, although the class Ib-restricting molecule and viral epitope remain to be identified (13).
###end p 8
###begin p 9
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1162 1164 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1166 1168 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 635 653 <span type="species:ncbi:10634">Mouse polyomavirus</span>
###xml 655 658 <span type="species:ncbi:10634">PyV</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 855 858 <span type="species:ncbi:10634">PyV</span>
###xml 1136 1139 <span type="species:ncbi:10634">PyV</span>
Polyomaviruses are highly prevalent vertebrate pathogens that generally cause a self-limited acute infection followed by long-term asymptomatic persistent infection in their natural host reservoir (14). In the immunosuppressed population, human polyomaviruses JC and BK can reactivate with severely debilitating consequences, including a typically fatal central nervous system demyelinating disease and allograft nephropathy, respectively (15, 16). Recently, two new human polyomaviruses have been identified in respiratory tract infections, and another has been associated with the cutaneous malignancy Merkel cell carcinoma (17-19). Mouse polyomavirus (PyV) establishes low-level systemic persistent infection and causes tumors in immunocompromised mice and neonatally infected mice of certain inbred strains (20). The approximately5-kb double-stranded PyV genome encodes only six proteins, three nonstructural proteins (small T, middle T [MT], and large T [LT] antigens) and three capsid proteins (VP1, VP2, and VP3). Interestingly, only peptides derived from the T antigens have been defined as epitopes for MHC class Ia-restricted PyV-specific CD8 T cells (14, 21).
###end p 9
###begin p 10
###xml 156 157 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 158 161 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 273 275 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 293 297 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 298 302 295 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 555 559 552 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 560 564 557 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 39 42 <span type="species:ncbi:10634">PyV</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 189 192 <span type="species:ncbi:10634">PyV</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 372 375 <span type="species:ncbi:10634">PyV</span>
###xml 456 459 <span type="species:ncbi:10634">PyV</span>
###xml 518 521 <span type="species:ncbi:10634">PyV</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 707 710 <span type="species:ncbi:10634">PyV</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
In this study, we investigated whether PyV infection elicits virus-specific CD8 T cells restricted by MHC class Ib molecules. We previously showed that beta2m-/- mice inefficiently control PyV infection, as indicated by the realization of this virus's oncogenic potential (22). Unexpectedly, Kb-/-Db-/- mice are highly resistant to tumor formation and efficiently control PyV infection, implicating MHC class Ia-independent CD8 T cells in surveillance for PyV-infected cells. We identified the ligand for the dominant PyV-specific CD8 T cell response in Kb-/-Db-/- mice as a VP2-derived nonameric peptide presented by Q9, a member of the Qa-2 family of Q region-encoded MHC class Ib molecules. Importantly, PyV infection also elicits Q9-restricted VP2-specific CD8 T cells in wild-type mice. Our findings provide the first formal demonstration of an antigen-specific class Ib-restricted CD8 T cell response that confers immunity to a viral infection.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin title 12
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 36 39 <span type="species:ncbi:10634">PyV</span>
MHC class Ia-deficient mice control PyV infection
###end title 12
###begin p 13
###xml 19 20 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 21 24 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 128 130 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 187 191 184 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 192 196 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 271 275 268 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 276 280 273 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 375 379 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 380 384 377 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 494 502 491 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 538 542 535 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 543 547 540 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 793 797 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 798 802 795 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 927 935 924 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 939 943 936 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 944 948 941 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1061 1069 1058 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1181 1185 1171 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1186 1190 1176 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 109 112 <span type="species:ncbi:10634">PyV</span>
###xml 150 153 <span type="species:ncbi:10634">PyV</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 227 230 <span type="species:ncbi:10634">PyV</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 402 405 <span type="species:ncbi:10634">PyV</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 755 758 <span type="species:ncbi:10634">PyV</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1052 1055 <span type="species:ncbi:10116">rat</span>
###xml 1164 1167 <span type="species:ncbi:10634">PyV</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
In contrast to beta2m-/- mice, which are both MHC class Ia- and class Ib-deficient and highly susceptible to PyV tumorigenesis (22), we observed that PyV-infected MHC class Ia-deficient Kb-/-Db-/- mice retain the resistance to PyV-induced tumors of B6 mice (3 out of 17 Kb-/-Db-/- mice developed tumors at 7 mo postinfection [p.i.]). Consistent with their tumor resistance, Kb-/-Db-/- mice clear acute PyV infection and check persistent viral replication with an efficiency similar to B6 mice (Fig. 1 A). Compared with B6 mice, however, Kb-/-Db-/- mice had a significantly higher viral load in the kidney (and a higher, but not significant, viral load in the spleen) at day 8 p.i. It is interesting to note that with this apparent lag in control of acute PyV infection, CD8 T cell numbers in Kb-/-Db-/- mice do not appreciably change until 25 d p.i. but then progressively increase well into the persistent phase of infection (Fig. 1 B). Kb-/-Db-/- mice depleted of CD8 T cells manifested significantly higher viral loads than those mice given control rat IgG (Fig. 1 C). Collectively, these data implicate non-MHC class Ia-restricted CD8alphabeta T cells in anti-PyV immunity in Kb-/-Db-/- mice.
###end p 13
###begin p 14
###xml 1 5 1 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 6 10 6 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K<sup>b&#8722;/&#8722;</sup>D<sup>b&#8722;/&#8722;</sup> mice control PyV replication.</bold>
###xml 177 181 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 182 186 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 208 212 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 213 217 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 24 27 <span type="species:ncbi:10634">PyV</span>
###xml 55 58 <span type="species:ncbi:10634">PyV</span>
###xml 163 166 <span type="species:ncbi:10634">PyV</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 279 282 <span type="species:ncbi:10116">rat</span>
###xml 296 299 <span type="species:ncbi:10634">PyV</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
Kb-/-Db-/- mice control PyV replication. (A) Levels of PyV DNA (+/-SEM) in organs at the indicated days p.i. (B) Number of splenic and lung CD8 T cells (+/-SD) in PyV-infected Kb-/-Db-/- mice over time. (C) Kb-/-Db-/- mice received either CD8-depleting mAb or an isotype control rat IgG, and the PyV genome copy numbers (+/-SEM) in the indicated organs were assayed on day 35 p.i. Data are the mean of three to five mice per group and are representative of two independent experiments. *, P </= 0.05; **, P </= 0.01.
###end p 14
###begin title 15
###xml 57 60 <span type="species:ncbi:10634">PyV</span>
Identification of the ligand for MHC class Ib-restricted PyV-specific CD8 T cells
###end title 15
###begin p 16
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 205 209 193 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 210 214 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 383 387 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 388 392 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 446 454 430 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 595 599 572 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 600 604 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 167 170 <span type="species:ncbi:10634">PyV</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 427 430 <span type="species:ncbi:10634">PyV</span>
###xml 575 578 <span type="species:ncbi:10634">PyV</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
Because of the small CD8 T cell compartment in Kb-/-Db-/- mice (approximately2% of splenic CD8 T cells in B6 mice), we were unable to reliably and consistently detect PyV-specific CD8 T cell responses in Kb-/-Db-/- mice ex vivo by IFN-gamma intracellular staining assays. To circumvent this obstacle, we isolated and established continuous cultures of T cell clones from individual Kb-/-Db-/- mice that specifically recognized PyV-infected APCs (Fig. 2 A). These CD8alphabeta (unpublished data) T cell clones provided the cellular reagents to define the ligands for the anti-PyV CD8 T cells in Kb-/-Db-/- mice.
###end p 16
###begin p 17
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q9-VP2.139 is the ligand for PyV-specific K<sup>b&#8722;/&#8722;</sup>D<sup>b&#8722;/&#8722;</sup> CD8 T cell clones.</bold>
###xml 118 122 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 123 127 123 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 180 184 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 573 577 561 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 578 582 566 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 29 32 <span type="species:ncbi:10634">PyV</span>
###xml 104 107 <span type="species:ncbi:10634">PyV</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 152 155 <span type="species:ncbi:10634">PyV</span>
###xml 209 212 <span type="species:ncbi:10634">PyV</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
Q9-VP2.139 is the ligand for PyV-specific Kb-/-Db-/- CD8 T cell clones. CD8 T cell clones isolated from PyV-infected Kb-/-Db-/- mice were stimulated by PyV-infected or uninfected Kb-/-Db-/- splenocytes (A) or PyV-infected or uninfected splenocytes from mice of the indicated strains (B) for 5 h, and analyzed for intracellular IFN-gamma. Data in B show the frequency of IFN-gamma-producing clone C3-8 cells; the same response pattern is shown by clone C1-21 (unpublished data). (C) Frequency of T cell clones stained intracellularly by anti-IFN-gamma after stimulation by Kb-/-Db-/- splenocytes in the presence of VP2.139 peptide or no added peptide. (D) Cytotoxic activity (+/-SD) by C1-21 and C3-8 T cell clones against VP2.139 peptide-coated control target cells (H1TAP.11) and target cells expressing Q8 (H1Q8TAP.11) or Q9 (H1Q9TAP.11). Without peptide, no specific lysis was seen by either cloned line against any of these target cells (unpublished data).
###end p 17
###begin p 18
###xml 52 53 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 86 90 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 91 95 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 99 100 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 101 104 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 133 137 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 138 142 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 230 231 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 262 270 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 336 341 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2-M3</italic>
###xml 343 347 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD1d</italic>
###xml 349 357 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 363 367 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Qa-1</italic>
###xml 645 649 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Qa-2</italic>
###xml 0 3 <span type="species:ncbi:10634">PyV</span>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 619 624 <span type="species:ncbi:10090">mouse</span>
PyV-infected spleen cells from mice lacking all beta2m-associated class I molecules (Kb-/-Db-/-beta2m-/-) failed to stimulate these Kb-/-Db-/- mouse-derived CD8 T cell clones, narrowing the candidate restriction elements to a beta2m-associated class I molecule (Fig. 2 B). Infected splenic APCs from B6 mice with targeted disruption of H2-M3, CD1d (Fig. 2 B), or Qa-1 (unpublished data) genes were recognized by the T cell clones, excluding these molecules as MHC class Ib-restricting elements. In contrast, the T cell clones did not produce IFN-gamma when co-cultured with infected APCs from B6.K1 mice, a congenic B6 mouse strain null for the Qa-2 locus, implicating a Qa-2 gene product as the MHC class Ib-restricting element.
###end p 18
###begin p 19
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 210 214 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 448 455 444 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 519 523 515 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 524 528 520 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 861 869 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 986 990 978 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 991 995 983 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1029 1037 1021 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1454 1456 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1548 1550 1540 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 120 123 <span type="species:ncbi:10634">PyV</span>
###xml 215 218 <span type="species:ncbi:10634">PyV</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 896 899 <span type="species:ncbi:10634">PyV</span>
###xml 996 1001 <span type="species:ncbi:10090">mouse</span>
Concomitant with these restriction mapping studies, we used libraries of 15-17mer overlapping peptides covering all six PyV proteins in an MHC-unbiased approach to define viral epitopes recognized by the Kb-/-Db-/- PyV-specific T cell clones. By testing the antigenicity of individual peptides in IFN-gamma ELISPOT assays, we found that only one 15mer peptide corresponding to aa 136-150 within the VP2 minor capsid protein, designated peptide 28 (Table I), stimulated each of two cloned lines isolated from different Kb-/-Db-/- mice (unpublished data). Coincidentally, this peptide contained sequences that satisfied the MHC anchor consensus motif for 8-9mer peptides bound to Qa-2 molecules: histidine at position 7 (numbered from the amino end), and a hydrophobic carboxy terminus. Of three 9mers having a histidine at P7 within the VP2 aa sequence 133-151 (Table II), only 139-147 of the VP2 PyV capsid protein (VP2.139) stimulated intracellular IFN-gamma production by all of the Kb-/-Db-/- mouse-derived CD8 T cell clones (Fig. 2 C). Single residue truncations of the VP2.139 peptide at the carboxy or amino terminus resulted in peptides that did not stimulate any of the clones, indicating that aa 139-147 of VP2 represent the minimum Qa-2-restricted epitope (unpublished data). Interestingly, the carboxy terminus of VP2.139 is occupied by tryptophan, a residue not detected at this position among endogenous peptides eluted from Qa-2 molecules (23); however, the Qa-2 F pocket is relatively spacious and can accommodate large side chains (24).
###end p 19
###begin p 20
###xml 57 60 <span type="species:ncbi:10634">PyV</span>
Overlapping VP2 peptides used to map the Qa-2-restricted PyV-specific T cell epitope
###end p 20
###begin p 21
Peptides fitting the Q9 peptide-binding motif
###end p 21
###begin p 22
###xml 285 287 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 360 364 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 365 369 357 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 611 613 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 628 636 620 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 867 871 859 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 872 876 864 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 370 373 <span type="species:ncbi:10634">PyV</span>
###xml 816 819 <span type="species:ncbi:10634">PyV</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
The Qa-2 family is composed of several members, of which Q9 is among the most thoroughly characterized mouse class Ib proteins. Q9 and another Qa-2 family member, Q8, share largely overlapping peptide-binding motifs, despite having >20 aa differences in the alpha1 and alpha2 domains (25). To determine whether Q8 and/or Q9 present the VP2.139 epitope to the Kb-/-Db-/- PyV-specific CD8 T cell clones, we used TAP2-deficient, MHC class Ia-negative B78H1 lines stably transfected with TAP2 and Q8 (H1Q8TAP.11), TAP2 and Q9 (H1Q9TAP11), or TAP2 and empty vector (H1TAP.11) as target cells in cytotoxicity assays (26). As shown in Fig. 2 D, only VP2.139 peptide-loaded cells expressing Q9 were recognized by these CD8 T cell clones. Collectively, these results define Q9-VP2.139 as the ligand for TCRs expressed by the PyV-specific CD8 T cell clone lines isolated from Kb-/-Db-/- mice.
###end p 22
###begin title 23
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Visualization of Q9-VP2.139-specific CD8 T cells in Kb-/-Db-/- mice
###end title 23
###begin p 24
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 303 307 303 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 308 312 308 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 373 381 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 653 657 653 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 658 662 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 916 924 916 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1223 1224 1223 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1371 1373 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1375 1377 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 152 155 <span type="species:ncbi:10634">PyV</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 340 343 <span type="species:ncbi:10634">PyV</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 473 476 <span type="species:ncbi:10634">PyV</span>
###xml 639 642 <span type="species:ncbi:10634">PyV</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 1183 1186 <span type="species:ncbi:10634">PyV</span>
We constructed Q9 tetramers complexed to the VP2.139 peptide to monitor the evolution of these novel antigen-specific CD8 T cells through the course of PyV infection. To confirm the specificity of the Q9-VP2.139 tetramers, we determined that tetramer+ CD8 T cells were readily detectable in spleens of Kb-/-Db-/- mice infected by wild-type PyV, but not in uninfected mice (Fig. 3 A). Moreover, the Q9-VP2.139 tetramer did not stain CD8 T cells in mice infected by a mutant PyV in which the Q9-anchoring histidine in the VP2.139 epitope was replaced by alanine (designated A2.H145A). Direct ex vivo Q9-VP2.139 tetramer staining showed that PyV-infected Kb-/-Db-/- mice did not generate a detectable antigen-specific CD8 T cell response in either spleen or lung until day 8 of infection, at which point VP2.139 epitope-specific CD8 T cells steadily increased in both frequency and magnitude into persistent infection (Fig. 3 B). Notably, by 80 d p.i., VP2.139-specific CD8 T cells represented nearly 80% of CD8 T cells in the lung and blood (unpublished data), and 40% of splenic CD8 T cells. This T cell response profile differs considerably from that of MHC class Ia-restricted anti-PyV CD8 T cell responses, where tetramer+ CD8 T cells are typically detected by 5 d p.i., peak in magnitude by 8 d p.i., and then quickly contract to a lower long-term steady-state level (14, 27).
###end p 24
###begin p 25
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evolution of the Q9-VP2.139&#8211;specific CD8 T cell response in K<sup>b&#8722;/&#8722;</sup>D<sup>b&#8722;/&#8722;</sup> mice.</bold>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 217 221 217 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 475 476 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 556 557 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 708 709 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 729 730 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 150 153 <span type="species:ncbi:10634">PyV</span>
###xml 203 206 <span type="species:ncbi:10634">PyV</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
Evolution of the Q9-VP2.139-specific CD8 T cell response in Kb-/-Db-/- mice. (A) Splenic Q9-VP2.139 tetramer+ CD8 T cells in uninfected, wild-type A2 PyV-infected, or VP2.139 epitopenull A2.H145A mutant PyV-infected Kb-/-Db-/- mice at day 40 p.i. Plots are gated on CD8+ cells, and values represent the percentage of cells within the indicated gate. (B) Numbers (left and middle) and frequency (right) of splenic and lung Q9-VP2.139 tetramer+ CD8 T cells (+/-SEM) over time (n = 3-9 mice at each of the indicated time points). (C) Splenic and lung tetramer+ cells were analyzed at days 35 (open) and 178 (shaded) p.i. (plots are representative of four to nine mice at each time point). Plots are gated on CD8+ Q9-VP2.139 tetramer+ cells.
###end p 25
###begin p 26
###xml 274 278 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 279 283 279 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 553 555 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 566 568 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 579 581 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 842 850 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 853 855 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 857 859 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1080 1082 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1084 1086 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1153 1154 1149 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1177 1179 1173 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1280 1282 1272 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1286 1288 1278 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1293 1295 1285 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1388 1390 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1746 1748 1738 1740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 202 205 <span type="species:ncbi:10634">PyV</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 1731 1734 <span type="species:ncbi:10634">PyV</span>
Chronic encounter by cognate antigen typically directs MHC class Ia-restricted CD8 T cells toward an effector differentiation state having curtailed effector competency. To determine whether persistent PyV infection similarly affected this antiviral CD8 T cell response in Kb-/-Db-/- mice, we phenotypically and functionally characterized VP2.139-specific CD8 T cells during their expansion (day 35 p.i.) and long-term maintenance (day 178 p.i.) phases. At day 35 p.i., Q9-VP2.139 tetramer+ CD8 T cells displayed an overall effector-like phenotype (CD44hi, CD94/NKG2hi, and CD122lo; unpublished data), but with a mixed CD43 (clone 1B11 epitope), CD62L-selectin, and IL-7Ralpha (CD127) expression pattern, and elevated expression of killer cell lectin-like receptor subfamily G, member 1 (KLRG1), a marker of short-lived effector CD8 T cells (Fig. 3 C) (28, 29). By day 178 p.i., however, the VP2.139-specific CD8 T cells assumed an unusual phenotype overlapping both effector and memory phenotypic profiles, consistent with repetitive antigenic stimulation of memory CD8 T cells (30, 31). Although nearly all of the maintenance-phase Q9-VP2.139 tetramer+ CD8 T cells were CD62Llo, they had reduced expression of CD27 and CD43, and increased levels of surface IL-7Ralpha. This CD27loCD43loCD127hi profile has been recently ascribed to CD8 T cells having strong recall response capability (32). Notably, VP2.139-specific CD8 T cells at days 35 and 178 p.i. did not express the inhibitory programmed death 1 receptor (unpublished data), which is often present on the surface of functionally impaired MHC class Ia-restricted antiviral CD8 T cells maintained in the setting of persistent viral infections, including those responding to PyV infection (33).
###end p 26
###begin p 27
###xml 33 37 33 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 259 267 255 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 462 470 450 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 475 483 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 541 545 529 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 546 550 534 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 625 629 613 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 630 634 618 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 680 682 668 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 715 717 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 858 862 846 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 863 867 851 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 944 952 932 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 117 120 <span type="species:ncbi:10634">PyV</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
VP2.139-specific CD8 T cells in Kb-/-Db-/- mice exhibited pronounced functional impairment. Throughout the course of PyV infection, <50% of VP2.139-specific CD8 T cells detected by tetramers produced intracellular IFN-gamma after VP2.139 peptide stimulation (Fig. 4 A). Interestingly, a fraction of the VP2.139-specific CD8 T cells acquired the ability to coproduce IFN-gamma and TNF-alpha at a late time point, when persistent infection viral loads had fallen (Fig. 1 A and Fig. 4 B). To assay antigen-specific cytotoxic activity in vivo, Kb-/-Db-/- mice infected 35 d earlier were injected with equal proportions of naive Kb-/-Db-/- splenocytes pulsed with VP2.139 peptide (CFSEhi labeled) or left untreated (CFSElo labeled). No specific elimination of peptide-coated target cells was seen 4 h after injection (unpublished data), but after 12 h, infected Kb-/-Db-/- mice demonstrated substantial specific clearance of VP2.139-coated targets (Fig. 4 C); the longer assay timeframe may enable colocalization of target cells with the low numbers of VP2.139-specific CD8 T cells, which, given their cytokine effector dysfunction, may also suffer reduced cytotoxic effector capability.
###end p 27
###begin p 28
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VP2.139-specific CD8 T cells have reduced effector function.</bold>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 137 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 174 178 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 179 183 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 267 268 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 278 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 334 338 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 339 343 329 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 458 462 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 463 467 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 513 515 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 539 541 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 585 589 567 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 590 594 572 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 601 602 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 571 574 <span type="species:ncbi:10634">PyV</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
VP2.139-specific CD8 T cells have reduced effector function. (A) Number of Q9-VP2.139 tetramer+ and VP2.139 peptide-stimulated IFN-gamma+ CD8 T cells (+/-SEM) in spleens of Kb-/-Db-/- mice at the indicated time points p.i. Values indicate the percentages of IFN-gamma+/tetramer+ CD8 T cells. (B) VP2.139-stimulated spleen cells from Kb-/-Db-/- mice stained for intracellular IFN-gamma and TNF-alpha at days 35 and 178 p.i. Plots are gated on CD8. (C) Naive Kb-/-Db-/- splenocytes coated with VP2.139 peptide (CFSEhi) or left uncoated (CFSElo) were injected into naive or PyV-infected Kb-/-Db-/- mice (n = 3) at day 35 p.i. 12 h later, splenocytes were harvested and analyzed by flow cytometry. Value indicates the percentage loss of peptide-coated target cells and is representative of two independent experiments.
###end p 28
###begin title 29
VP2.139-specific CD8 T cells confer antiviral immunity
###end title 29
###begin p 30
###xml 157 161 157 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 162 166 162 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 264 272 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 609 617 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 622 630 622 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 686 690 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 691 695 691 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 237 240 <span type="species:ncbi:10634">PyV</span>
###xml 491 494 <span type="species:ncbi:10634">PyV</span>
###xml 696 700 <span type="species:ncbi:10090">mice</span>
###xml 1044 1052 <span type="species:ncbi:10629">BK virus</span>
###xml 1054 1062 <span type="species:ncbi:10632">JC virus</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
###xml 1074 1077 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We used two approaches to directly determine whether VP2.139-specific CD8 T cells operated to protect the host from viral infection. We first asked whether Kb-/-Db-/- mice were able to control infection by the VP2.139 epitopenull mutant PyV, A2.H145A. As shown in Fig. 5 A, at day 5 p.i. no differences were seen in viral load between the parental and mutant viruses in multiple organs (spleen and kidney are shown). Thus, this single mutation at aa 145 in VP2 did not alter the capacity of PyV to replicate and disseminate in vivo at a time point preceding the emergence of a detectable CD8 T cell response (Fig. 1 B and Fig. 3 B). During persistent infection (day 80 p.i.), however, Kb-/-Db-/- mice infected by the A2.H145A virus had 100-fold more viral DNA in their kidneys than the parental A2-infected animals. This difference was not seen in the spleen or salivary glands (unpublished data), possibly pointing toward the importance of immune surveillance in an organ prone to harboring viruses that persistently infect their hosts (e.g., BK virus, JC virus, and human CMV).
###end p 30
###begin p 31
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VP2.139-specific CD8 T cells are protective.</bold>
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 120 124 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 273 277 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 278 282 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 328 329 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 370 371 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 422 426 420 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 427 431 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 94 97 <span type="species:ncbi:10634">PyV</span>
###xml 141 144 <span type="species:ncbi:10634">PyV</span>
###xml 156 159 <span type="species:ncbi:10634">PyV</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
VP2.139-specific CD8 T cells are protective. (A) Kb-/-Db-/- mice were infected by parental A2 PyV or the VP2.139 epitopenull A2.H145A mutant PyV. Levels of PyV DNA (+/-SEM) in the spleen and kidney were determined by quantitative PCR at the indicated time points p.i. (B) Kb-/-Db-/- mice were infected by A2 or A2.H145A PyVs (106 PFU) and simultaneously received 20 x 106 splenocytes from A2 virus-infected (day 35 p.i.) Kb-/-Db-/- splenocytes. Virus levels in the indicated organs were assayed as in A at days 5-6 p.i. of five to six mice pooled from two independent experiments. **, P < 0.0001; *, P < 0.001.
###end p 31
###begin p 32
###xml 105 109 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 199 203 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 204 208 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 243 247 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 248 252 248 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 434 438 434 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">null</sup>
###xml 451 459 451 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 561 565 561 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 566 570 566 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 138 141 <span type="species:ncbi:10634">PyV</span>
###xml 171 174 <span type="species:ncbi:10634">PyV</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 406 409 <span type="species:ncbi:10634">PyV</span>
###xml 446 449 <span type="species:ncbi:10634">PyV</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
Second, we used an adoptive transfer approach to ask whether VP2.139-specific CD8 T cells could protect Kb-/-Db-/- mice against a primary PyV infection. Spleen cells from PyV-infected (day 35 p.i.) Kb-/-Db-/- mice were transferred into naive Kb-/-Db-/- mice that were simultaneously infected either by A2 or A2.H145A PyVs. On day 5 p.i., virus levels were significantly lower in recipients of the parental PyV than the VP2.139 epitopenull mutant PyV (Fig. 5 B). Collectively, these studies indicate that VP2.139-specific CD8 T cells mediate viral clearance in Kb-/-Db-/- mice.
###end p 32
###begin title 33
###xml 3 7 <span type="species:ncbi:10090">mice</span>
B6 mice generate Q9-VP2.139-specific CD8 T cells
###end title 33
###begin p 34
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 580 588 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 920 921 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1065 1073 1053 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 1096 1100 1084 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1101 1105 1089 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1246 1247 1230 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1336 1344 1316 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 1493 1494 1473 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1514 1522 1494 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 21 24 <span type="species:ncbi:10634">PyV</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 456 459 <span type="species:ncbi:10634">PyV</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 1058 1063 <span type="species:ncbi:10090">mouse</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1616 1619 <span type="species:ncbi:10634">PyV</span>
###xml 1672 1676 <span type="species:ncbi:10090">mice</span>
To determine whether PyV infection elicits Q9-restricted VP2.139-specific CD8 T cells in B6 mice, we initially used our standard inoculation dose of 106 PFU and monitored blood and spleen over the course of infection for CD8 T cells that bound Q9-VP2.139 tetramers. Under these conditions, we were unable to detect VP2.139-specific CD8 T cells (unpublished data). Based on our recent finding that antigen-nonspecific bystander inflammation associated with PyV infection impairs the antiviral CD8 T cell response (33), we reduced the viral inoculation dose 1,000-fold. As shown in Fig. 6 A, Q9-VP2.139 tetramers now stained CD8 T cells in approximately one third of infected B6 mice at day 11 p.i., the peak magnitude of the VP2.139-specific CD8 T cell response (unpublished data). The Q9-VP2.139-specific CD8 T cells constitute 0.5-2% of splenic CD8 T cells in B6 responders to this epitope, compared with the dominant Db-aa 359-368 of LT (LT359) CD8 T cell response, which occupied approximately16% of the splenic CD8 T cell compartment in each infected B6 mouse (Fig. 6 B). As was seen in the Kb-/-Db-/- mice, only a fraction of the Q9-VP2.139-specific CD8 T cells in B6 mice produced IFN-gamma after peptide stimulation; however, most of the Db-restricted LT359-specific CD8 T cells detected by tetramer staining produced IFN-gamma (Fig. 6 C). Coincident with this functional deficit, Q9-VP2.139 CD8 T cells express a higher level of surface KLRG1 and a lower level of CD127 compared with Db-LT359 CD8 T cells (Fig. 6 D). Thus, although MHC class Ib-restricted antiviral CD8 T cells are indeed recruited into the PyV-specific CD8 T cell response in acutely infected B6 mice, these T cells appear to be more terminally differentiated at this time point than the MHC class Ia-restricted antiviral CD8 T cells.
###end p 34
###begin p 35
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PyV-infected B6 mice generate a Q9-VP2.139&#8211;specific CD8 T cell response.</bold>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 641 642 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 770 771 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 786 787 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 802 803 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 3 <span type="species:ncbi:10634">PyV</span>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 157 160 <span type="species:ncbi:10634">PyV</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
PyV-infected B6 mice generate a Q9-VP2.139-specific CD8 T cell response. (A) Frequency of Q9-VP2.139+ cells of CD8 T cells in the blood, spleen, and lung of PyV-infected (day 11 p.i.) B6 mice (n = 32). (B) Representative dot plots of splenic Q9-VP2.139 tetramer+ and Db-LT359 tetramer+ CD8 T cells from B6 mice at day 11 p.i. Plots are gated on CD8 T cells. Values indicate percentages of CD8 T cells that are tetramer+. (C) VP2.139 and LT359 peptide-stimulated spleen cells from the same mice shown in B were analyzed for intracellular IFN-gamma. Plots are gated on CD8 T cells. Values indicate percentages of CD8 T cells that are IFN-gamma+. (D) Expression of the indicated surface molecules by splenic CD8 T cells from naive mice (dashed line) and Q9-VP2.139 tetramer+ (shaded) and Db-LT359 tetramer+ CD8 T cells (continuous line) from infected (day 11 p.i.) B6 mice.
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
###xml 221 225 221 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 472 473 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 725 727 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 918 919 915 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 928 930 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 932 934 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 1137 1139 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 269 272 <span type="species:ncbi:10634">PyV</span>
###xml 704 709 <span type="species:ncbi:10090">mouse</span>
In this study, we identified a novel MHC class Ib peptide ligand for virus-specific CD8 T cells and demonstrated that these antiviral T cells confer protection against infection. We found that the MHC class Ia-deficient Kb-/-Db-/- mice efficiently control infection by PyV and mount an antiviral CD8 T cell response that is predominantly directed toward a viral capsid-derived nonamer peptide bound to Q9, a member of the Qa-2 family of MHC class Ib molecules. Of the beta2m-associated MHC class I products encoded in the Qa-2 locus, only Q9-restricted T cell responses have been previously shown to contribute to host immunity. An early report showed that expression of Q9 correlated with resistance to mouse cysticercosis (34). More recently, it has been demonstrated that immunization by Q9-expressing tumor cells elicits Q9-restricted CTLs, which are capable of cross-protecting against histologically disparate Q9+ tumors (35, 36). A role for Q9-restricted CD8 T cells in antiviral immunity has been postulated and is supported by evidence that synthetic peptides from several viral proteins are capable of binding to Q9 molecules (37). To our knowledge, however, the data presented in this paper represent the first identification of a Qa-2-restricted T cell epitope and the first description of a MHC class Ib-restricted virus-specific CD8 T cell response in vivo.
###end p 37
###begin p 38
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 1013 1017 1013 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1018 1022 1018 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 1371 1372 1368 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1373 1376 1370 1373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1383 1385 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1581 1583 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 1585 1587 1582 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 284 287 <span type="species:ncbi:10634">PyV</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
###xml 427 430 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 636 670 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
###xml 687 690 <span type="species:ncbi:10634">PyV</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1205 1208 <span type="species:ncbi:10634">PyV</span>
###xml 1289 1292 <span type="species:ncbi:10634">PyV</span>
###xml 1377 1381 <span type="species:ncbi:10090">mice</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
An unusual feature of the Q9-restricted CD8 T cell response in Kb-/-Db-/- mice is its steady accumulation during persistent infection. Naive virus-specific CD8 T cells primed de novo during persistent infection are primarily responsible for maintaining stable numbers of conventional PyV-specific CD8 T cells (38) and are also a source of cells supplying the inflationary viral epitope-specific CD8 T cell populations in mouse CMV infection (Snyder, C., K.S. Cho, and A.B. Hill, personal communication). Although antigen-driven proliferation of virus-specific CD8 T cells has been shown to maintain CD8 T cell numbers during persistent lymphocytic choriomeningitis virus infection (39), PyV-specific MHC class Ia-restricted T cells undergo gradual attrition and fail to divide in persistently infected wild-type mice (38, 40). Whether de novo priming of naive T cells or self-renewal of effector/memory T cells predominantly accounts for the accumulation of VP2.139-specific CD8 T cells in persistently infected Kb-/-Db-/- mice is currently under investigation. The progressive increase in Q9-VP2.139-specific CD8 T cell numbers may also suggest that viral capsid proteins are expressed during persistent PyV infection. In support of this possibility, VP1 capsid proteins are expressed in PyV-induced tumors (41) and in the kidneys and lungs of persistently infected beta2m-/- mice (22). Interestingly, HLA-A2-restricted CD8 T cells directed to peptides derived from VP1 represent dominant specificities of human polyomavirus-specific CD8 T cells responses in healthy individuals (42, 43). Whether structural proteins are synthesized continuously during low-level "smoldering" infection by polyomavirus or are transiently resurrected from a dormant state is currently unknown.
###end p 38
###begin p 39
###xml 87 91 87 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 92 96 92 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 366 370 366 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 528 532 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 533 537 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 684 700 684 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L. monocytogenes</italic>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 717 721 717 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 722 726 722 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 975 979 975 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 980 984 980 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 1083 1084 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1249 1251 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1253 1255 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1964 1966 1957 1959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 2333 2341 2326 2334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 684 700 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1184 1187 <span type="species:ncbi:10634">PyV</span>
###xml 1742 1745 <span type="species:ncbi:10634">PyV</span>
###xml 2284 2288 <span type="species:ncbi:10090">mice</span>
###xml 2297 2300 <span type="species:ncbi:10634">PyV</span>
A central finding of this study is that the peripheral T cell compartments of both H-2Kb-/-Db-/- and parental B6 mice contain a reservoir of virus-specific Q9-restricted CD8 T cells. The character of this response, however, differs depending on the level of MHC class Ia sufficiency. The Q9-VP2.139-specific CD8 T cell response is strikingly immunodominant in Kb-/-Db-/- mice but constitutes a subdominant, variable response in acutely infected B6 mice. A straightforward explanation is that MHC class Ib-restricted T cells in Kb-/-Db-/- mice would not encounter immunodomination by MHC class Ia-restricted T cells, as described for the H2-M3-restricted memory CD8 T cell response to L. monocytogenes (44). Thus, in Kb-/-Db-/- mice, VP2.139-specific CD8 T cells would have unfettered access to viral epitope-expressing cells, as well as to mitogenic and survival cytokines. A related factor may be that Q9 surface expression (and presumably Q9 epitope density) is higher in Kb-/-Db-/- mice than in MHC class Ia-sufficient mice (45), possibly because of a lack of competition for beta2m and MHC class I chaperone molecules. It is also worth noting that to date we have identified anti-PyV CD8 T cell epitopes only from the nonstructural LTs and MTs (14, 21), which are encoded by an early region transcript and are expressed by both productively and nonproductively infected cells. In contrast, the VP2.139 epitope is derived from a late-region viral capsid protein, whose synthesis is limited to productively infected cells. One possibility is that the Q9-VP2.139 CD8 T cell response may be at a disadvantage compared with MHC class Ia-restricted LT/MT-specific CD8 T cell responses both in timing of expression of the VP2 protein during the PyV lifecycle and the number and range of cells presenting the VP2.139 epitope. Alternatively, Q9 cell-surface expression, like MHC class Ia molecules, is up-regulated by certain inflammatory cytokines, such as IFN-gamma (46), and may thus be subject to modulation in the context of virus infection. Thus, viral capsid-specific CD8 T cells may preferentially operate during persistent infection to contain pockets of active viral infection, a possibility supported by evidence that the VP2.139-specific CD8 T cells from persistently infected mice control PyV in acutely infected recipients (Fig. 5 B).
###end p 39
###begin p 40
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 310 312 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 561 563 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 680 684 672 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 685 689 677 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 951 953 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 955 957 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 1019 1022 1007 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1089 1090 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1132 1134 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 177 181 <span type="species:ncbi:10090">Mice</span>
###xml 651 654 <span type="species:ncbi:10634">PyV</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1102 1105 <span type="species:ncbi:10634">PyV</span>
The inability of Q9 to efficiently use CD8 coreceptors (47) may contribute to the reduced magnitude and effector capability of CD8 T cells restricted by this class Ib molecule. Mice transgenic for a recombinant MHC class Ia molecule whose alpha3 domain was exchanged for that of Q7 (which is identical to Q9) (48) show profound inefficiency in the selection of MHC class I alloreactive CD8 CTLs. The recently solved Q9 crystal structure reveals that the AB loop of Q9's alpha3 domain points away from where it would normally bind CD8 in MHC class Ia molecules (24). A small pool of VP2.139-specific naive T cells may explain the delay in expansion of PyV-specific CD8 T cells in Kb-/-Db-/- mice. Weak CD8 engagement may also raise T cell activation thresholds for Q9-restricted T cells, requiring elevated epitope densities to achieve full effector potential and possibly altering the differentiation of T cells recruited into the antiviral response (49, 50). In this connection, it is interesting to note that CD8alpha-/- mice mount a delayed, cytokine effector function-handicapped, H-2Db-restricted PyV-specific T cell response (40).
###end p 40
###begin p 41
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1048 1056 1048 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 219 224 <span type="species:ncbi:9606">human</span>
###xml 225 228 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 474 477 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The central question is to what extent MHC class Ib-restricted T cells contribute to viral immunity. MHC class Ib-restricted CD8 T cells may provide a contingency for the host against viral immune evasion. For example, human CMV encodes a mimic MHC class Ia leader peptide, UL40, which binds to HLA-E and engages inhibitory CD94/NKG2A receptors on NK cells (51). Yet, HLA-E/UL40-specific CD8 T cells with cytokine and cytotoxic effector capabilities have been isolated from CMV-seropositive individuals (12). From a general perspective, MHC class Ib-restricted CD8 T cells expand epitope diversity of the antiviral immune response and protect against immune selection of epitope-escape viral variants. More specifically, because the dominant antiviral CD8 T cell response is directed toward MHC class Ia-presented epitopes, MHC class Ib-restricted T cells may assume importance as a failsafe antiviral defense strategy. From the surface phenotype of the VP2.139-specific CD8 T cells, which suggests recall-competent effector/effector-memory cells (Fig. 3 C), it is tempting to speculate that MHC class Ib-restricted T cells may be play a substantial role in limiting persistent viral infection.
###end p 41
###begin p 42
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 450 453 <span type="species:ncbi:10634">PyV</span>
###xml 724 730 <span type="species:ncbi:9606">humans</span>
Because MHC class Ib molecules have few polymorphisms, identification of MHC class Ib-restricted epitopes would offer much more comprehensive coverage across a population for peptide-based CD8 T cell-mediated immunotherapy than can be achieved by immunization using MHC class Ia-restricted peptides. Although Q9 is a mouse-only MHC class Ib molecule, HLA-G has been proposed to constitute its functional human homologue (52). It is also notable that PyV is unique among avian and mammalian polyomaviruses in possessing a VP2.139 sequence available for binding to Q9 (53). This apparent example of host-pathogen coevolution lends additional support toward uncovering MHC class Ib-restricted antiviral CD8 T cell responses in humans, with the prospect of developing seemingly "non-MHC-restricted" epitope-based vaccinations for viral infections.
###end p 42
###begin title 43
MATERIALS AND METHODS
###end title 43
###begin title 44
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 44
###begin p 45
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 144 148 144 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 151 155 151 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 395 399 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
C57BL/6NCr (B6) female mice were purchased from the Frederick Cancer Research and Development Center of the National Cancer Institute. H2-Kb-/-Db-/- (Kb-/-Db-/-) mice (45) were obtained from Taconic. H2-M3-/- (54), CD1d-/- (55), Qa-1b-/- (56), and B6.K1 (57) mice have been previously described. Spleens from Qa-1b-/- mice were provided by H. Cantor (Dana-Farber Cancer Institute, Boston, MA). Kb-/-Db-/- mice were bred and housed by the Department of Animal Resources at Emory University in accordance with the guidelines of the university's Institutional Animal Care and Use Committee. All mice were between 6 and 8 wk of age at the time of infection.
###end p 45
###begin title 46
Cell lines.
###end title 46
###begin p 47
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
The derivation and maintenance of the B78H1 transfectants expressing TAP2 (designated H1TAP.11), TAP2 and Q8 (designated H1Q8TAP.11), or TAP2 and Q9 (designated H1Q9TAP.11) have been previously described (25).
###end p 47
###begin title 48
Viruses and cell transfers.
###end title 48
###begin p 49
###xml 1 5 1 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 6 10 6 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 246 248 246 248 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GC</underline>
###xml 304 306 304 306 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GC</underline>
###xml 528 532 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 533 537 533 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 567 571 567 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 572 576 572 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 676 680 676 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 681 685 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 755 759 755 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 760 764 760 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 64 67 <span type="species:ncbi:10634">PyV</span>
###xml 514 517 <span type="species:ncbi:10634">PyV</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 719 722 <span type="species:ncbi:10634">PyV</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 867 870 <span type="species:ncbi:10634">PyV</span>
Kb-/-Db-/- and B6 mice were infected s.c. by 106 and 103 PFU of PyV (A2 strain), respectively, in hind footpads. The A2.H145A mutant virus was created using PCR-based site-directed mutagenesis of A2 genomic DNA (forward primer, 5'-GCTCTAAATGTAGTAGCTGATTGGGGCCATGGC-3'; reverse primer, 5'-GCCATGGCCCCAATCAGCTACTACATTTAGAGC-3'; mutation nucleotides are underlined) to change the codon for aa 145 in the VP2 protein from histidine to alanine. A VP2.139-147 (145A) analogue peptide did not stimulate spleen cells from PyV-infected Kb-/-Db-/- mice, and A2.H145A-infected Kb-/-Db-/- mice did not generate VP2.139-specific CD8 T cells (unpublished data). 20 x 106 spleen cells from Kb-/-Db-/- mice at day 35 p.i. by wild-type PyV were transferred i.v. to naive Kb-/-Db-/- mice, which were inoculated immediately after transfer with 106 PFU of parental A2 or mutant A2.H145A PyV.
###end p 49
###begin title 50
###xml 16 19 <span type="species:ncbi:10634">PyV</span>
Quantitation of PyV genomes.
###end title 50
###begin p 51
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 90 93 <span type="species:ncbi:10634">PyV</span>
###xml 214 217 <span type="species:ncbi:10634">PyV</span>
DNA isolation and Taqman-based real-time PCR were performed as previously described (14). PyV DNA quantity is expressed in genome copies per milligram of tissue and is calculated based on a standard curve of known PyV genome copy numbers versus threshold cycle of detection. The detection limit with this assay is 10 copies of genomic viral DNA.
###end p 51
###begin title 52
Synthetic peptides.
###end title 52
###begin p 53
###xml 52 60 52 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
VP2.133-141, VP2.139-147, and VP2.143-151 peptides (Table II) and LT359-368Abu peptide (33) were synthesized by the solid-phase method using F-moc chemistries. Peptide stocks were solubilized in water or DMSO and stored at -20degreesC. Peptides were diluted in assay medium immediately before use. The MT and LT peptide libraries, consisting of 17mer peptides overlapping by 12 aa, were prepared as PepSets by Chiron and were provided by J. Altman (Emory Vaccine Center, Atlanta, GA); the VP1 and VP2 peptide libraries, consisting of 15mer peptides overlapping by 10 aa, were prepared on a peptide synthesizer (Symphony/Multiplex; Rainin). The MT peptide library includes all of the small T antigen except for its four carboxy-terminal aa, and the VP2 peptide library covers the entire VP3 sequence.
###end p 53
###begin title 54
###xml 17 20 <span type="species:ncbi:10634">PyV</span>
Establishment of PyV-specific CD8 T cell cloned lines.
###end title 54
###begin p 55
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 157 161 157 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 201 205 197 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 206 210 202 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 249 251 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 0 3 <span type="species:ncbi:10634">PyV</span>
###xml 126 129 <span type="species:ncbi:10634">PyV</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
PyV-specific CD8 T cells were cloned by limiting dilution from in vitro secondary cultures of popliteal lymph node cells from PyV-immune (2-3 wk p.i.) Kb-/-Db-/- mice using infected, gamma-irradiated Kb-/-Db-/- splenocytes, as previously described (58).
###end p 55
###begin title 56
Cell isolation and flow cytometry.
###end title 56
###begin p 57
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 741 743 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Single-cell suspensions were made of popliteal lymph node cells and RBC-lysed spleens. For lung lymphocyte isolation, mice were perfused with PBS containing 100 U/ml heparin, and lungs were digested in vitro by collagenase and centrifuged on Percoll step gradients, as previously described (59). Antibodies to CD8alpha, CD43, CD44, CD62L, and NKG2A/C/E (clone 20d5) were purchased from BD Biosciences and used according to the manufacturer's specifications. Anti-CD27, anti-CD127, and anti-programmed death 1 were purchased from eBioscience. Anti-KLRG1 was purchased from SouthernBiotech. Q9-VP2.139 tetramers were constructed by the National Institutes of Health Tetramer Core Facility at Emory University using cloned full-length Q9 cDNA (60). Tetramer staining was performed, along with antibody surface staining for 35 min at room temperature in PBS containing 2% FBS and 0.1% sodium azide. Samples were acquired on a FACSCalibur (BD Biosciences), and data were analyzed using FlowJo software (Tree Star, Inc.).
###end p 57
###begin title 58
IFN-gamma ELISPOT assay.
###end title 58
###begin p 59
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 236 240 232 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 241 245 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 273 277 269 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 278 282 274 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 334 338 330 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 339 343 335 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 863 864 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 865 866 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 259 262 <span type="species:ncbi:10634">PyV</span>
###xml 464 467 <span type="species:ncbi:10634">PyV</span>
###xml 683 694 <span type="species:ncbi:3704">horseradish</span>
Single-cell ELISPOT assays were performed as previously described (17). In brief, 96-well filtration plates (Millipore) were coated overnight with anti-IFN-gamma (R4-6A2; BD Biosciences). 2 wk after stimulation by infected, irradiated Kb-/-Db-/- splenocytes, PyV-specific Kb-/-Db-/- CD8 T cell cloned lines were incubated with naive Kb-/-Db-/- splenocytes for 36 h at 37degreesC with individual overlapping peptides encompassing sequences for MT, LT, VP1, and VP2 PyV proteins. The final concentration of each peptide was approximately10 muM. After the incubation, plates were washed and incubated with biotinylated anti-IFN-gamma (XMG1.2; BD Biosciences). Wells were incubated with horseradish peroxidase-avidin D (Vector Laboratories), washed, and developed with freshly prepared substrate buffer (0.03% [wt/vol] 3-amino-9-ethyl-carbazole and 0.015% [vol/vol] H2O2 in 0.1 M sodium acetate, pH 5).
###end p 59
###begin title 60
Intracellular antibody staining.
###end title 60
###begin p 61
###xml 198 200 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 598 603 <span type="species:ncbi:9606">human</span>
Cells were stimulated directly ex vivo with 1 muM VP2.139 peptide for 5 h in the presence of brefeldin A, and were then stained for surface CD8 and intracellular cytokines, as previously described (14). For assays using CD8 T cell clones, the clones were labeled with CFSE to distinguish them from splenic stimulator cells. mAbs to IFN-gamma and TNF-alpha were purchased from BD Biosciences. For granzyme B staining, spleen cells were surface stained directly ex vivo with anti-CD8alpha and Q9-VP2.139 tetramers, permeabilized using the Cytofix/Cytoperm kit (BD Biosciences), and stained with anti-human granzyme B or the isotype control antibody (Invitrogen).
###end p 61
###begin title 62
In vivo CD8 T cell depletion.
###end title 62
###begin p 63
###xml 85 87 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 477 478 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 279 282 <span type="species:ncbi:10116">rat</span>
###xml 386 389 <span type="species:ncbi:10634">PyV</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
CD8beta mAb (clone H35; provided by P. Allen, Washington University, St. Louis, MO) (61) was prepared in flasks (INTEGRA Celline CL1000; Integra Biosciences) using defined IgG-free medium (Invitrogen), according to the manufacturer's instructions. 1 mg anti-CD8beta or ChromPure rat IgG (Jackson ImmunoResearch Laboratories) was administered i.p. on days -3, -1, and +1 from the day of PyV infection, with antibodies given every 5 d up to day 30 p.i. No CD8alpha-expressing CD3+ T cells were detected in spleens of CD8beta mAb-treated mice at day 35 p.i. (unpublished data).
###end p 63
###begin title 64
In vivo cytotoxicity assay.
###end title 64
###begin p 65
###xml 54 58 54 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 235 236 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 514 515 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 611 612 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 725 729 718 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 730 734 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b&#8722;/&#8722;</sup>
###xml 847 849 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib62">62</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
RBC-lysed, single-cell spleen suspensions from naive Kb-/-Db-/- mice were pulsed at 107 cells/ml with 10 muM VP2.139 peptide or without peptide in DMEM containing 10% FBS for 30 min at 37degreesC. Each cell population was stained at 107 cells/ml in HBSS (Invitrogen) with 2 mM CellTrace Far Red DDAO-SE (Invitrogen) at room temperature for 10 min, with labeling stopped by addition of an equal volume of FBS for 1 min. Each cell population was labeled with a different concentration of CFSE (1 or 0.1 mM) at 2 x 107 cells/ml in HBSS, with labeling stopped by addition of an equal volume of FBS for 1 min. 5 x 106 no-peptide and VP2.139 peptide-pulsed cells were mixed together and injected i.v. into infected and uninfected Kb-/-Db-/- mice. Specific elimination of donor cells was determined at 4 and 12 h after transfer, as previously described (62).
###end p 65
###begin title 66
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
51Cr release assay.
###end title 66
###begin p 67
###xml 100 101 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 101 103 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 106 107 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 227 229 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 521 523 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 574 576 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 368 371 <span type="species:ncbi:10634">PyV</span>
Adherent H1TAP.11, H1Q8TAP.11, and H1Q9TAP.11 target cells were radiolabeled with 150-200 muCi of Na251CrO4 (400-1,200 Ci/g; PerkinElmer) and pulsed with 10 muM VP2.139 peptide at 37degreesC for 1.5 h, as described previously (58). Target cells were aliquotted at 5,000 cells per well into U-bottom 96-well microtiter plates and co-cultured at 37degreesC for 5 h with PyV-specific CD8 T cell cloned lines at the effector/target (E:T) ratios indicated in the figures in quadruplicate wells, and the percentage of specific 51Cr release was determined as previously described (58).
###end p 67
###begin title 68
Statistical analysis.
###end title 68
###begin p 69
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistics were performed using statistical software (Prism; GraphPad Software, Inc.). All analyses were unpaired Student's t tests. P </= 0.05 was considered statistically significant.
###end p 69
###begin p 70
###xml 77 80 <span type="species:ncbi:10634">PyV</span>
We thank Anna Lukacher for her contributions in creating the A2.H145A mutant PyV and Eva Szomolanyi-Tsuda for critically reviewing this manuscript.
###end p 70
###begin p 71
This work was supported by National Institutes of Health grants R01CA71971 and R01CA100644 (to A.E. Lukacher), R01AI33614 (to P.E. Jensen), R01AI40310 (to C.-R. Wang), and RO1AI19624 (to I. Stroynowski).
###end p 71
###begin p 72
The authors have no conflicting financial interests.
###end p 72

